Epidemiologic study on anti-toxoplasma gondii antibodies prevalence in an obstetric population;Studio epidemiologico sulla prevalenza degli anticorpi anti-toxoplasma gondii in una popolazione ostetrica

Italian Journal of Gynaecology and Obstetrics

Volumn 20, Issue 3, 2008, Pages 159-166

  Masini, L ^a   Casarella, L ^a   Grillo, R L ^a   Zannella, M P ^a   Oliva, G C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Epidemiology; Pregnancy; Prevalence; Toxoplasmosis

Indexed keywords

COTRIMOXAZOLE; PROTOZOON ANTIBODY; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; SULFADIAZINE; SULFADIMIDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; DELIVERY ROOM; ECHOGRAPHY; ETHNICITY; FEMALE; FETUS DEATH; GYNECOLOGIC INFECTION; HUMAN; ITALY; LIVE BIRTH; MAJOR CLINICAL STUDY; OBSTETRIC CARE; PATIENT EDUCATION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; REFUSAL TO PARTICIPATE; SEROCONVERSION; SPONTANEOUS ABORTION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 56549123154     PISSN: 11218339     EISSN: 23850868     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Stray-Pedersen B. A prospective study of acquired toxoplasmosis among 8.043 pregnant women in the Oslo area. Am J Obstet Gynecol 1980;136(3): 399-406.
2. Buffolano W, Gilbert RE, Holland FJ, Fatta D, Palumbo F, Ades AE. Risk factor for recent Toxoplasma infection in pregnant women in Naples. Epidemiol Infect 116: 347-351, 1996
3. Cook AJC, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 2000;321: 142-147.
4. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez PH. Prenatal management of 746 pregnancies at risk for Congenital Toxoplasmosis. New Engl Med J 1988;318: 271-275.
5. Masini L, Noia G, De Santis M, Masciullo G, Bartolucci L, Ranno O, Valentini P, Bellati U, Caruso A, Mancuso S. Toxoplasmosis in pregnancy: epidemiology, maternal treatment and neonatal follow-up. Proceeding: "First International meeting of the genetic and reproductive epidemiology research society" Roma, 9/12/1991, Eds. Mastroiacovo P, Kallen B, Castilla EE. Ghedini Ed., Milano: 65-69, 1992.
6. Hohlfeld P, MacAleese J, Capella-Pavlovsky M, Giovangrandi Y, Thulliez P, Forestier F, Daffos F. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol 1991;1(4): 241-244.
7. Jacquemard F. Signes echographiques de la toxoplasmose congenitale. Arch Ped 2003; 10: 35-38.
8. Bailao LA, Osborne NG, Rizzi MCS, Bonilla-Musoles F, Duarte G, Sicchieri Bailao TCR. Ultrasound markers of fetal infection, Part 2 Bacterial, parasitic, and fungal infections. Ultrasound Quarterly 2006; 22(2): 137-151.
9. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a Polymerase-Chain-Reaction test on amniotic fluid. New Engl J Med 1994; 331: 695-699.
10. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001;97: 296-300.
11. Grillo RL, Speziale D, Santangelo L, Masini L, De Santis M, Noia G, Caruso A, Ranno O, Valentini P, Fadda G. Persistent low IgG level in 4 pregnant women at risk of Toxoplasma Gondii infection. Atti "European Conference on Congenital Toxoplasmosis" Vienna, June 29-July 1, 2000.
12. Foulon W, Villena I Stray-Pedersen B, Decoster A, Lappalaine n M, Pinon JM, Jenum PA, Hedman K, Naessens A. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410-415.
13. Ambroise-Thomas P., Scheizer M., Pinon J.M., Thiebaugeorges O. Prevention of congenital toxoplasmosis in France, risk assessment, results and perspectives of prenatal screening and newborn follow-up. Bull Acad Natl Med 2001; 185: 668-683.
14. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R. Risk factors for Toxoplasma Gondii infection in mothers of infants with congenital toxoplasmosis: implication for prenatal management and screening. AMJ Obstet Gynecol 2005;192: 564-571.
15. Gilbert RE, Gras L, Wallon, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma Gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001; 30: 1303-1308.
16. Gilbert RE, Tan HK, Cliffe S, Guy E, Stanford M. Symptomatic Toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child 2006;91: 494-498.
17. Eskild A, Fallås Dahl G, Melby KK, Nesheim BI. Testing for toxoplasmosis in pregnancy: a study of theroutines in primary antenatal care. J Med Screen 2003; 10: 172-175.
18. Nucera E, Roncallo C, Masini L, Buonomo A, De Pasquale T, Pollastrini E, Schiavino D, Patriarca G. Successful tolerance induction to spyramicin in pregnancy. Scand J Infect Dis 2002; 34(7): 550-1.
19. Nucera E, Schiavino D, Buonomo A, Del Ninno M, Sun JY, Patriarca G. Tolerance induction to cotrimoxazolo. Allergy 55(7):681-2, 2000.
20. Vergani P, Ghidini A, Ceruti P, Stroebelt N, Spelta A, Zapparoli B, Rescaldani R. Congenital toxoplasmosis: efficacy of maternal treatment with spyramicin alone. Am J Reprod Immunol 1998;39(5): 335-340.